An Alzheimer's pill appears to protect some in a high-risk population
toggle caption Jorg Greuel/Photodisc/Getty Images
In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801.
Researchers had just released topline results of a study of more than 300 people age 50 or older, who were genetically predisposed to Alzheimer's. Overall, those who got the drug did no better than those given a placebo.
But in September, a closer look at the results revealed benefits for a subgroup of 125 people who had only mild memory problems when they started taking the drug.
Those participants, initially diagnosed
Continue Reading on NPR
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.